Peter Th.A. Schellekens

Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy

Jan M. Prins, Suzanne Jurriaans, Rieneke M. E. van Praag et al. · AIDS · 1999 · 240 citations

Life Sciences, Immunology, Infectious Diseases +17

The Effect of Two Different Dosages of Intravenous Immunoglobulin on the Incidence of Recurrent Infections in Patients with Primary Hypogammaglobulinemia

H.W. Eijkhout, J.W.M. van der Meer, Cees G. M. Kallenberg et al. · Annals of Internal Medicine · 2001 · 238 citations

Life Sciences, Pharmacology, Pharmacotherapy +12

Herpes zoster, immunological deterioration and disease progression in HIV-1 infection

Jan A. Veenstra, Anneke Krol, Rieneke M. E. van Praag et al. · AIDS · 1995 · 109 citations

Veterinary Medicine, Immunology, Infectious Diseases +15

Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men

Peter Th.A. Schellekens, Marijke Th. L. Roos, Frank de Wolf et al. · Journal of Clinical Immunology · 1990 · 104 citations

Life Sciences, Immunology, Infectious Diseases +17

Changes in the Composition of Circulating CD8⁺T Cell Subsets during Acute Epstein‐Barr and Human Immunodeficiency Virus Infections in Humans

Marijke Th. L. Roos, René A. W. van Lier, Dörte Hamann et al. · The Journal of Infectious Diseases · 2000 · 101 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17